Cargando…

Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

Detalles Bibliográficos
Autores principales: Sattar, Naveed, McLaren, James, Kristensen, Søren L., Preiss, David, McMurray, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969788/
https://www.ncbi.nlm.nih.gov/pubmed/27174369
http://dx.doi.org/10.1007/s00125-016-3987-3
_version_ 1782445843032309760
author Sattar, Naveed
McLaren, James
Kristensen, Søren L.
Preiss, David
McMurray, John J.
author_facet Sattar, Naveed
McLaren, James
Kristensen, Søren L.
Preiss, David
McMurray, John J.
author_sort Sattar, Naveed
collection PubMed
description
format Online
Article
Text
id pubmed-4969788
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49697882016-08-17 Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Sattar, Naveed McLaren, James Kristensen, Søren L. Preiss, David McMurray, John J. Diabetologia Erratum Springer Berlin Heidelberg 2016-05-12 2016 /pmc/articles/PMC4969788/ /pubmed/27174369 http://dx.doi.org/10.1007/s00125-016-3987-3 Text en © Springer-Verlag Berlin Heidelberg 2016
spellingShingle Erratum
Sattar, Naveed
McLaren, James
Kristensen, Søren L.
Preiss, David
McMurray, John J.
Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title_full Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title_fullStr Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title_full_unstemmed Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title_short Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
title_sort erratum to: sglt2 inhibition and cardiovascular events: why did empa-reg outcomes surprise and what were the likely mechanisms?
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969788/
https://www.ncbi.nlm.nih.gov/pubmed/27174369
http://dx.doi.org/10.1007/s00125-016-3987-3
work_keys_str_mv AT sattarnaveed erratumtosglt2inhibitionandcardiovasculareventswhydidemparegoutcomessurpriseandwhatwerethelikelymechanisms
AT mclarenjames erratumtosglt2inhibitionandcardiovasculareventswhydidemparegoutcomessurpriseandwhatwerethelikelymechanisms
AT kristensensørenl erratumtosglt2inhibitionandcardiovasculareventswhydidemparegoutcomessurpriseandwhatwerethelikelymechanisms
AT preissdavid erratumtosglt2inhibitionandcardiovasculareventswhydidemparegoutcomessurpriseandwhatwerethelikelymechanisms
AT mcmurrayjohnj erratumtosglt2inhibitionandcardiovasculareventswhydidemparegoutcomessurpriseandwhatwerethelikelymechanisms